Skip to main content
AGIO logo
AGIO
(NASDAQ)
Agios Pharmaceuticals, Inc.
$36.28-- (--)
Loading... - Market loading

Agios Pharmaceuticals (AGIO) Stock Price & Financial Analysis

Agios Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$35.09 - $36.68
52-Week High$46.00
52-Week Low$22.24
Open$35.14
Volume778.07K
Average Volume (3M)1.24M
Market Cap2.13B
Shares Outstanding58.78M
Price to Sales (P/S)32.29
Price to Book (P/B)0.88
EV/EBITDA-4.79
Revenue (TTM)66.05M
Net Income (TTM)-422.60M
Free Cash Flow (TTM)-384.73M
EPS (TTM)$-7.25
Profit Margin-639.84%
Operating Margin-719.97%
Return on Equity (ROE)-17.38%
Debt to Equity0.01
50-Day MA$33.45
200-Day MA$31.83
52-Week Change-10.55%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Agios Pharmaceuticals

What is the current stock price for AGIO?

As of the latest trading session, AGIO stock trades at $36.28. The 52-week range is $22.24–$46.00, with a day range of $35.09–$36.68.

What is the P/E ratio for AGIO?

The P/E ratio (Price-to-Earnings) for AGIO is shown in the Key Statistics section. This valuation metric helps compare Agios Pharmaceuticals, Inc. to industry peers.

Does AGIO pay dividends?

Agios Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AGIO?

Based on 8 analysts, the consensus for AGIO is Buy.

What is the market cap of AGIO?

Agios Pharmaceuticals's market capitalization is $2.13B, classifying it as a mid-cap company. Agios Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.